A phase 3 trial of Aldeyra Therapeutics’ dry eye disease prospect has hit its primary endpoint, preparing the biotech to seek approval for a candidate the FDA has rejected twice in recent years.

Reproxalap 0.25% was superior to vehicle-control on ocular discomfort symptom score from 80 to 100 minutes after chamber entry. Reproxalap ophthalmic solution 0.25% reached the primary endpoint in ...

Researchers at Aston University have called for more advice to be given to young people about preventing dry eye disease, after a study carried out in conjunction with Oslo University Hospital and ...

Nearly 76,000 cases of eye drops have been recalled nationwide by BRS Analytical Services, a pharmaceutical consulting firm, according to an FDA enforcement report.

There are several eye concerns linked to diabetes, one of which is dry eyes. This might sound like a minor inconvenience, but chronic dry eyes, also known as dry eye syndrome or dry eye disease ...

It can be difficult to diagnose dry eye properly because it’s one of many conditions that can make your eyes feel dry or uncomfortable. Consulting a qualified ophthalmologist or optometrist can ...

According to the FDA, over 75,000 cases of five different eye drops and artificial tears were recalled. Here's what you need ...

Are your eyes red and irritated by the end of a day at the office? Do letters start looking blurry after hours of staring at the computer screen? These are symptoms of dry eye. Surveys of American ...

If your eyes sting and burn, look red, or feel gritty -- as if some sand is stuck in them -- you may have dry eye. This condition can happen when the tiny glands in and around your eyelids don't ...

A Recently Completed Dry Eye Disease Field Trial, which Was Numerically Supportive of Reproxalap and Consistent with Prior Field Trials, Did Not Reach Statistical Significance, and Is Expected to ...